Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
Q2 2025 vs. Q1 2025
How the institutions holding Cidara Therapeutics, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 46 | 109 | +63 |
| Shares | 9.56M | 25.9M | +16.4M (+171.1%) |
| Value | $205.9M | $1.26B | +$1.06B (+513.3%) |
New holders (71)
Institutions that held Cidara Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (8)
Institutions that held Cidara Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Checkpoint Capital L.P. | 104,380 | $2.25M |
| Millennium Management LLC | 63,580 | $1.37M |
| 5AM Venture Management, LLC | 56,725 | $1.22M |
| Jane Street Group, LLC | 27,849 | $599.9K |
| Omers Administration Corp | 19,300 | $415.7K |
| Alethea Capital Management, LLC | 14,311 | $308.3K |
| Point72 Asia (Singapore) Pte. Ltd. | 1,552 | $33.4K |
| Point72 (DIFC) Ltd | 469 | $10.1K |